5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
Recruiting · NCT04610372 · Registry updated 2026-05-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT) | Oligometastatic Prostate Cancer | Recruiting | Not applicable | 2026-05-06 | NCT04610372 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| British Columbia Cancer Agency | 58 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| British Columbia Cancer Agency Center for the Southern Interior | Kelowna | Canada | 5 |
| Fraser Valley Cancer Center | Surrey | Canada | 1 |
| Vancouver Cancer Center | Vancouver | Canada | 1 |
| Vancouver Island Cancer Center | Victoria | Canada | 1 |